LT3183264T - Pegilinimo būdas - Google Patents
Pegilinimo būdasInfo
- Publication number
- LT3183264T LT3183264T LTEP15763443.7T LT15763443T LT3183264T LT 3183264 T LT3183264 T LT 3183264T LT 15763443 T LT15763443 T LT 15763443T LT 3183264 T LT3183264 T LT 3183264T
- Authority
- LT
- Lithuania
- Prior art keywords
- pegilation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461997000P | 2014-08-19 | 2014-08-19 | |
PCT/US2015/045678 WO2017030563A1 (en) | 2014-08-19 | 2015-08-18 | Pegylation method |
Publications (1)
Publication Number | Publication Date |
---|---|
LT3183264T true LT3183264T (lt) | 2021-01-11 |
Family
ID=59559468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEP15763443.7T LT3183264T (lt) | 2014-08-19 | 2015-08-18 | Pegilinimo būdas |
Country Status (13)
Country | Link |
---|---|
US (1) | US11318207B2 (lt) |
EP (2) | EP3782652A1 (lt) |
CO (1) | CO2017002512A2 (lt) |
CY (1) | CY1123685T1 (lt) |
DK (1) | DK3183264T3 (lt) |
ES (1) | ES2824028T3 (lt) |
HR (1) | HRP20201725T1 (lt) |
LT (1) | LT3183264T (lt) |
MX (1) | MX2017002140A (lt) |
RS (1) | RS61128B1 (lt) |
SI (1) | SI3183264T1 (lt) |
SM (1) | SMT202100016T1 (lt) |
WO (1) | WO2017030563A1 (lt) |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
EP0082481B2 (en) | 1981-12-23 | 1990-09-12 | Schering Corporation | Stabilised alpha-interferon formulations and their preparation |
US4917888A (en) | 1985-06-26 | 1990-04-17 | Cetus Corporation | Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation |
US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
JP2514950B2 (ja) | 1986-03-10 | 1996-07-10 | エフ・ホフマン―ラ ロシユ アーゲー | 化学修飾蛋白質,その製造法および中間体 |
US5595732A (en) | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
US5262564A (en) | 1992-10-30 | 1993-11-16 | Octamer, Inc. | Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents |
WO1995013090A1 (en) | 1993-11-10 | 1995-05-18 | Enzon, Inc. | Improved interferon polymer conjugates |
PL193352B1 (pl) | 1998-04-28 | 2007-02-28 | Applied Research Systems | Koniugat poliol-interferon ß, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna |
TWI266801B (en) | 1999-07-26 | 2006-11-21 | Applied Research Systems | Polyol-IFN-beta conjugates |
EA009783B1 (ru) * | 2002-01-18 | 2008-04-28 | Байоджен Айдек Ма Инк. | Полиалкиленгликоль с остатком для конъюгации биологически активного соединения |
CA2498062C (en) * | 2002-09-27 | 2010-05-25 | F. Hoffmann-La Roche Ag | Conjugates of insulin-like growth factor binding protein-4 and poly(ethylene glycol) |
US20040180054A1 (en) | 2003-03-13 | 2004-09-16 | Hanmi Pharm. Co., Ltd. | Physiologically active polypeptide conjugate having prolonged in vivo half-life |
CU23556A1 (es) | 2005-11-30 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Estructura polimérica semejante a dendrímero para la obtención de conjugados de interés farmacéutico |
GB0908393D0 (en) | 2009-05-15 | 2009-06-24 | Almac Sciences Scotland Ltd | Labelling method |
WO2011075391A1 (en) * | 2009-12-15 | 2011-06-23 | Schering Corporation | Formulations of acadesine |
AR080993A1 (es) | 2010-04-02 | 2012-05-30 | Hanmi Holdings Co Ltd | Formulacion de accion prolongada de interferon beta donde se usa un fragmento de inmunoglobulina |
CN102453089B (zh) | 2010-10-25 | 2014-06-04 | 北京凯因科技股份有限公司 | 重组集成干扰素变异体聚乙二醇偶联物的制备和应用 |
WO2014130811A1 (en) * | 2013-02-22 | 2014-08-28 | Biogen Idec Ma Inc | Interferon beta formulation |
CN103113466B (zh) | 2013-03-01 | 2015-06-03 | 中国科学院过程工程研究所 | 聚乙二醇修饰的重组人干扰素β-1b及制备方法 |
CN103936847B (zh) | 2013-12-24 | 2014-12-10 | 北京凯因科技股份有限公司 | Peg-sa及其药物组合物 |
-
2015
- 2015-08-18 US US15/504,379 patent/US11318207B2/en active Active
- 2015-08-18 DK DK15763443.7T patent/DK3183264T3/da active
- 2015-08-18 EP EP20180909.2A patent/EP3782652A1/en active Pending
- 2015-08-18 ES ES15763443T patent/ES2824028T3/es active Active
- 2015-08-18 RS RS20201286A patent/RS61128B1/sr unknown
- 2015-08-18 MX MX2017002140A patent/MX2017002140A/es unknown
- 2015-08-18 EP EP15763443.7A patent/EP3183264B1/en active Active
- 2015-08-18 SM SM20210016T patent/SMT202100016T1/it unknown
- 2015-08-18 WO PCT/US2015/045678 patent/WO2017030563A1/en active Application Filing
- 2015-08-18 LT LTEP15763443.7T patent/LT3183264T/lt unknown
- 2015-08-18 SI SI201531401T patent/SI3183264T1/sl unknown
-
2017
- 2017-03-16 CO CONC2017/0002512A patent/CO2017002512A2/es unknown
-
2020
- 2020-10-26 HR HRP20201725TT patent/HRP20201725T1/hr unknown
- 2020-10-27 CY CY20201101014T patent/CY1123685T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK3183264T3 (da) | 2020-11-02 |
BR112017003162A2 (pt) | 2017-11-28 |
RS61128B1 (sr) | 2020-12-31 |
US20170232111A1 (en) | 2017-08-17 |
CO2017002512A2 (es) | 2017-05-31 |
EP3183264B1 (en) | 2020-07-29 |
CY1123685T1 (el) | 2022-03-24 |
US11318207B2 (en) | 2022-05-03 |
ES2824028T3 (es) | 2021-05-11 |
SI3183264T1 (sl) | 2021-03-31 |
EP3183264A1 (en) | 2017-06-28 |
WO2017030563A8 (en) | 2017-03-16 |
EP3782652A1 (en) | 2021-02-24 |
SMT202100016T1 (it) | 2021-03-15 |
HRP20201725T1 (hr) | 2021-03-05 |
MX2017002140A (es) | 2017-08-21 |
WO2017030563A1 (en) | 2017-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL3167096T3 (pl) | Dwuetapowy sposób nanoszenia | |
HUE042335T2 (hu) | ROR-gamma dihidropirrolopiridin inhibitorai | |
DK3183051T3 (da) | Væske-til-luftmembranenergivekslere | |
DK3134402T3 (da) | 4-amino-imidazoquinolinforbindelser | |
DK3211743T3 (da) | Ø-til-netværk-omskiftningsfremgangsmåde | |
DK3006072T3 (da) | Karadgang | |
DK3222714T3 (da) | Phytasemutanter | |
DK3119396T3 (da) | Muscarinreceptoragonister | |
EP3230438C0 (en) | N-GLYCOSYLATION | |
DK3186242T3 (da) | Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere | |
DK3132009T3 (da) | Fremgangsmåde | |
DK3110442T3 (da) | Modificerede meningokok-fhbp-polypeptider | |
PL3393468T3 (pl) | Metody leczenia niedoboru odporności | |
DK3283210T3 (da) | Fremgangsmåde | |
DE112015001664A5 (de) | Betätigungsaktuator | |
DK3183340T3 (da) | Termolabile exonukleaser | |
DK3154703T3 (da) | Fuldkappe-snekkecentrifuge | |
DK3110439T3 (da) | Pcsk9-vacciner | |
IL248608A0 (en) | Heparan sulphates | |
IL252086A0 (en) | Novel methods | |
DE112015005041A5 (de) | Gargerätevorrichtung | |
FR3024647B1 (fr) | Transat de puericulture | |
DK3009858T3 (da) | Skyradar | |
DK3285588T3 (da) | Fremgangsmåde | |
DE112015001633A5 (de) | Betätigungsaktuator |